|
Volumn 57, Issue 6, 1996, Pages 265-269
|
Incentive bias?
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DOSULEPIN;
FLUOXETINE;
PAROXETINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
1 NAPHTHYLAMINE;
DRUG DERIVATIVE;
CLINICAL TRIAL;
DEPRESSION;
DOSE RESPONSE;
DRUG COST;
DRUG MARKETING;
HUMAN;
LETTER;
PRIORITY JOURNAL;
DRUG ADMINISTRATION;
DRUG INDUSTRY;
ECONOMICS;
FINANCIAL MANAGEMENT;
NOTE;
TREATMENT OUTCOME;
SOCIAL PSYCHOLOGY;
1-NAPHTHYLAMINE;
CLINICAL TRIALS;
DEPRESSIVE DISORDER;
DRUG ADMINISTRATION SCHEDULE;
DRUG COSTS;
DRUG INDUSTRY;
FINANCIAL SUPPORT;
HUMANS;
SEROTONIN UPTAKE INHIBITORS;
SERTRALINE;
TREATMENT OUTCOME;
DEPRESSION;
PAROXETINE;
PREJUDICE;
|
EID: 0030037418
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (2)
|
References (0)
|